Showing results (471-480 of 585) with videos related to

Sort By:
Pageof 59
Journal of Gastroenterology and Hepatology|April 18, 2024
Changes in characteristics of gastroenterology center inpatients in Japan because of rapidly aging societyYoshiko Fukunishi, Atsushi Hiraoka, Fujimasa Tada, et al.
Oncology|July 16, 2019
Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular CarcinomaAtsushi Hiraoka, Takashi Kumada, Masanori Atsukawa, et al.
Nature Genetics|September 15, 2009
Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis CYasuhito Tanaka, Nao Nishida, Masaya Sugiyama, et al.
Liver Cancer|February 20, 2020
Post-Progression Treatment Eligibility of Unresectable Hepatocellular Carcinoma Patients Treated with LenvatinibAtsushi Hiraoka, Takashi Kumada, Shinya Fukunishi, et al.
Hepatology (Baltimore, Md.)|August 15, 2012
FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinomaTokuzo Arao, Kazuomi Ueshima, Kazuko Matsumoto, et al.
Human Genetics|December 18, 2014
Genome-wide association study identifies a PSMD3 variant associated with neutropenia in interferon-based therapy for chronic hepatitis CEtsuko Iio, Kentaro Matsuura, Nao Nishida, et al.
The American Journal of Gastroenterology|August 16, 2022
A Novel SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102): An International Multicenter Cohort StudyChuan Liu, Zhujun Cao, Huadong Yan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 18, 2020
Neutrophil-to-lymphocyte ratio is associated with survival in patients with unresectable hepatocellular carcinoma treated with lenvatinibToshifumi Tada, Takashi Kumada, Atsushi Hiraoka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 4, 2025
Employment Status of Patients With Liver Disease: A Nationwide Questionnaire Survey in JapanYoshio Tokumoto, Yoichi Hiasa, Yoshihito Uchida, et al.
JHEP Reports : Innovation in Hepatology|August 18, 2025
Restoration of the gut-microbiota-liver axis after hepatitis C virus eradicationTakako Inoue, Jiro Nakayama, Hiroshi Mori, et al.
Pageof 59